| Clinical Study "Common" Name (formal title) | Number of enrollees | Funding source (pharma/NIH) | Year complete | Primary publication | Full study treatment protocol |
|---|---|---|---|---|---|
|
CRAVE (Comparison of Anti-VEGF Agents in the Treatment of Macular Edema from Retinal Vein Occlusion Trial) |
98 | Barnes Retina Institute | 2015 |
Rajagopal R, Shah GK, Blinder KJ, et al. Bevacizumab versus ranibizumab in the treatment of macular edema due to retinal vein occlusion: 6-month results of the CRAVE study. Ophthalmic Surg Lasers Imaging Retina. 2015;46(8):844-850. https://www.healio.com/ophthalmology/journals/osli/2015-9-46-8/%7B0189bab6-2f59-4b08-b15b-a054188ba8e8%7D/bevacizumab-versus-ranibizumab-in-the-treatment-of-macular-edema-due-to-retinal-vein-occlusion-6-month-results-of-the-crave-study |
|